OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Computational screening and MM/GBSA-based MD simulation studies reveal the high binding potential of FDA-approved drugs againstCutibacterium acnessialidase
Akash Pratap Singh, Shaban Ahmad, Khalid Raza, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 12, pp. 6245-6255
Closed Access | Times Cited: 11
Akash Pratap Singh, Shaban Ahmad, Khalid Raza, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 12, pp. 6245-6255
Closed Access | Times Cited: 11
Showing 11 citing articles:
Investigating the Inhibitory Effects of Paliperidone on RAGEs: Docking, DFT, MD Simulations, MMPBSA, MTT, Apoptosis, and Immunoblotting Studies
Akash Pratap Singh, Shaban Ahmad, Anamika Roy, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1060-1060
Open Access
Akash Pratap Singh, Shaban Ahmad, Anamika Roy, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1060-1060
Open Access
Structure-Based In Silico Approaches Reveal IRESSA as a Multitargeted Breast Cancer Regulatory, Signalling, and Receptor Protein Inhibitor
Hassan H. Almasoudi, Mutaib M. Mashraqi, Saleh Alshamrani, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 208-208
Open Access | Times Cited: 2
Hassan H. Almasoudi, Mutaib M. Mashraqi, Saleh Alshamrani, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 208-208
Open Access | Times Cited: 2
Identification of Druggable Binding Sites and Small Molecules as Modulators of TMC1
Pedro De‐la‐Torre, Claudia Martínez-García, Paul Gratias, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Pedro De‐la‐Torre, Claudia Martínez-García, Paul Gratias, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Delineated 3-1-BenCarMethInYlPro-Phosphonic Acid’s Adroit Activity against Lung Cancer through Multitargeted Docking, MM\GBSA, QM-DFT and Multiscale Simulations
Mohammed Ageeli Hakami, Ali Hazazi, Fawaz Albloui, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 592-592
Open Access | Times Cited: 1
Mohammed Ageeli Hakami, Ali Hazazi, Fawaz Albloui, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 592-592
Open Access | Times Cited: 1
Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer
Abdulkarim S. Binshaya, Omar Saad Alkahtani, Fahad M. Aldakheel, et al.
Medical Oncology (2024) Vol. 41, Iss. 5
Closed Access | Times Cited: 1
Abdulkarim S. Binshaya, Omar Saad Alkahtani, Fahad M. Aldakheel, et al.
Medical Oncology (2024) Vol. 41, Iss. 5
Closed Access | Times Cited: 1
Delineating Pixantrone Maleate’s adroit activity against cervical cancer proteins through multitargeted docking-based MM\GBSA, QM-DFT and MD simulation
Hassan H. Almasoudi, Mohammed H. Nahari, Abdulfattah Yahya M. Alhazmi, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0295714-e0295714
Open Access | Times Cited: 4
Hassan H. Almasoudi, Mohammed H. Nahari, Abdulfattah Yahya M. Alhazmi, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0295714-e0295714
Open Access | Times Cited: 4
Mitoxantrone 2HCl’s adroit activity against cervical cancer replication and maintenance proteins: a multitargeted approach
Mohammed Ageeli Hakami, Ali Hazazi, Mishal Olayan Alsulami, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-14
Closed Access
Mohammed Ageeli Hakami, Ali Hazazi, Mishal Olayan Alsulami, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-14
Closed Access
Unrevealing the multitargeted potency of 3-1-BCMIYPPA against lung cancer structural maintenance and suppression proteins through pharmacokinetics, QM-DFT, and multiscale MD simulation studies
Mohammed Ali Alshehri, Saeed Asiri, Nawal Helmi, et al.
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0303784-e0303784
Open Access
Mohammed Ali Alshehri, Saeed Asiri, Nawal Helmi, et al.
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0303784-e0303784
Open Access
Towards identification of therapeutics against multi-infections and cancers causing Propionibacterium acnes: Molecular modeling and dynamics simulation investigation
Abdulaziz A. Aloliqi
Journal of Molecular Liquids (2024) Vol. 415, pp. 126373-126373
Closed Access
Abdulaziz A. Aloliqi
Journal of Molecular Liquids (2024) Vol. 415, pp. 126373-126373
Closed Access
Multitargeted inhibitory effect of Mitoxantrone 2HCl on cervical cancer cell cycle regulatory proteins: a multitargeted docking-based MM\GBSA and MD simulation study
Mohammed Ali Alshehri, Saeed Ahmed Asiri, Abdulrahman Alzahrani, et al.
Medical Oncology (2023) Vol. 40, Iss. 11
Open Access | Times Cited: 1
Mohammed Ali Alshehri, Saeed Ahmed Asiri, Abdulrahman Alzahrani, et al.
Medical Oncology (2023) Vol. 40, Iss. 11
Open Access | Times Cited: 1
Cheminformatics approach for identification of N-HyMenatPimeMelly as a novel potential ligand against RAS and renal chloride channel
Hussam Murad, Misbahudin Rafeeq
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 23, pp. 12836-12850
Closed Access
Hussam Murad, Misbahudin Rafeeq
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 23, pp. 12836-12850
Closed Access
